BBHC
RPRX icon

Brown Brothers Harriman & Co’s Royalty Pharma RPRX Stock Holding History

Brown Brothers Harriman & Co’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.2K Hold
253
– – ﹤0.01% 1356
2026
Q1 		$12.1K Hold
253
– – ﹤0.01% 1320
2025
Q4 		$9.78K Buy
253
+115
+83% +$4.38K ﹤0.01% 1347
2025
Q3 		$4.87K Hold
138
– – ﹤0.01% 1420
2025
Q2 		$4.97K Buy
+138
New +$4.57K ﹤0.01% 1271

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Brown Brothers Harriman & Co's RPRX Position: Q2 2026 in Review

Brown Brothers Harriman & Co held its Royalty Pharma (RPRX) position steady in Q2 2026 at 253 shares worth $14.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1356.

Brown Brothers Harriman & Co first reported a position in RPRX in Q2 2025 and has held it in 5 quarters since. 643 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Brown Brothers Harriman & Co held 253 shares of Royalty Pharma worth $14.2K as of Q2 2026.
  • Brown Brothers Harriman & Co left its Royalty Pharma share count unchanged in Q2 2026.
  • Royalty Pharma made up ﹤0.01% of Brown Brothers Harriman & Co's portfolio in Q2 2026, its #1356 holding.
  • Brown Brothers Harriman & Co first reported a position in Royalty Pharma in Q2 2025 and has held it in 5 quarters since.
  • 643 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Brown Brothers Harriman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.